PDP-LEVETIRACETAM

pendopharm division of pharmascience inc🇨🇦 Health Canada

Approval Id: fc461fdb5c552aad
Drug Approval Canada Name: PDP-LEVETIRACETAM
Product Name: PDP-LEVETIRACETAM
Status: Marketed
Status Date: 2020-05-01
Original Market Date: 2020-05-01
Din: 02490447
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N03AX14 LEVETIRACETAM
Atc Name: n 03 ax 14
Aig Number: 0148843005
Company Name: pendopharm division of pharmascience inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4

LEVETIRACETAM

100 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fc461fdb5c552aad

Type

Standard